The clinical outcomes of the GC patients are summarized, including CEA, CA19−9, AFP, and HER2 expression, pathologic grade, Union for International Cancer Control (UICC) tumor stage, lymph node involvement, and distant metastases (Figure 1B, Table 1 and Table 2). The gene discussed is AFP; the disease is gastric cancer.